Work

Results of the randomized Intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.10507

Authors: Veronique Minard-Colin, Anne Auperin, Marta Pillon, Amos Burke, James Robert Anderson, Donald A. Barkauskas, Keith Wheatley, Rafael Delgado, Sarah Alexander, Anne Uyttebroeck, Catherine Bollard, Jozsef Zsiros, Monika Csoka, Gisele Goma, Anne Tulard, Catherine Patte, Thomas G. Gross

Institutions: Institut Gustave Roussy, Addenbrooke's Hospital, University of Southern California, University of Birmingham, Hospital for Sick Children, Universitair Ziekenhuis Leuven, Children's National, Emma Kinderziekenhuis, Semmelweis University, National Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2733090892

Cites:

Cited by: 81

Related to: 10